MARKET

FBIO

FBIO

Fortress Biotech Inc
NASDAQ
3.270
+0.340
+11.60%
After Hours: 3.270 0 0.00% 19:37 02/06 EST
OPEN
3.020
PREV CLOSE
2.930
HIGH
3.270
LOW
3.000
VOLUME
627.45K
TURNOVER
--
52 WEEK HIGH
4.530
52 WEEK LOW
1.325
MARKET CAP
101.49M
P/E (TTM)
-11.1604
1D
5D
1M
3M
1Y
5Y
1D
Weekly Report: what happened at FBIO last week (0126-0130)?
Weekly Report · 5d ago
Weekly Report: what happened at FBIO last week (0119-0123)?
Weekly Report · 01/26 10:07
Weekly Report: what happened at FBIO last week (0112-0116)?
Weekly Report · 01/19 10:12
Weekly Buzz: LYRA Slashes Jobs; FDA Okays FBIO's ZYCUBO; BSX To Acquire PEN; BCTX On Watch
NASDAQ · 01/16 13:58
BUZZ-U.S. STOCKS ON THE MOVE-Albemarle, Lowe's, nLIGHT
Reuters · 01/13 15:42
Fortress Biotech Gains FDA Approval for Menkes Treatment
TipRanks · 01/13 14:49
FORTRESS BIOTECH SHARES HIT NEAR TWO-WEEK LOW, LAST DOWN 6.6%
Reuters · 01/13 14:46
Cyprium Therapeutics Wins FDA Approval for ZYCUBO in Menkes Disease
Reuters · 01/13 14:20
More
About FBIO
Fortress Biotech, Inc. is a biopharmaceutical company focused on acquiring and advancing assets. The Company has eight marketed prescription pharmaceutical products and over 20 programs in development, with its majority-owned and majority-controlled partners and subsidiaries and partners and subsidiaries it founded and in which it holds significant minority ownership positions. Its portfolio is being commercialized and developed for various therapeutic areas, including oncology, dermatology, and rare diseases. Its dermatology products include Emrosi, Qbrexza, Amzeeq, Zilxi, Exelderm, Targadox, and Luxamend. Its late-stage product candidates include CUTX-101 (copper histidinate injection for Menkes disease), Triplex (cytomegalovirus (CMV) vaccine), and CAEL-101 (monoclonal antibody for AL amyloidosis). Its early and mid-stage product candidates include Dotinurad (urate transporter (URAT1) inhibitor for gout), MB-101 (IL13Rα2 CAR T Cell Program for Glioblastoma), and others.

Webull offers Fortress Biotech Inc stock information, including NASDAQ: FBIO real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, FBIO stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading FBIO stock methods without spending real money on the virtual paper trading platform.